SKC Staff Publications

SKC Staff Publications

Dr. Hefsa

Publications

  1. Al Shamsi HR, Shaheen I, Aziz D. Management of recurrent focal segmental glomerulosclerosis (FSGS) post renal transplantation. Transplant Rev (Orlando). 2022 Jan;36(1):100675. doi: 10.1016/j.trre.2021.100675. Epub 2021 Dec 18. PMID: 34952298.
  2. Abdulle A, Inman CK, Saleh A, Noshi M, Galani D, Abdelwareth L, Alsafar H, Elfatih A, Al Shamsi H, Ali R, Li H, Ramasamy R, Schmidt AM, Benbarka MM, Hassan MH. Metabolic dysfunction in Emirati subjects in Abu Dhabi: Relationship to levels of solubleRAGEs. J Clin Transl Endocrinol. 2019 Apr 23;16:100192. doi: 10.1016/j.jcte.2019.100192. PMID: 31080742; PMCID: PMC6503160.
  3. Al Shamsi H, El Tahrawi R, Hindawy B, Khater E, Hassan M. Multicenter Review of Glomerular Diseases in the Emirates of Abu Dhabi: Six Years’ Experience. Saudi J Kidney Dis Transpl. 2020 Sep-Oct;31(5):1069-1077. doi: 10.4103/1319-2442.301173. PMID: 33229771.
  4. Alshamsi I, Alshamsi H, Al Falahi S, Sharma A, Halawa A. Perinephric transplant fluid collection approach and management. Saudi J Kidney Dis Transpl. 2019 May-Jun;30(3):564-570. doi: 10.4103/1319-2442.261328. PMID: 31249219.

Dr. Emad Sudqi Khater

Publications

  1. Feasibility of routine ultrasound-guided percutaneous transluminal angioplasty in the treatment of native arteriovenous fistula dysfunction
    Antonio Granata et al. J Vasc Access. 2020.
    J Vasc Access. 2020 Jul 25;1129729820943076.
    doi: 10.1177/1129729820943076. Online ahead of print.
    Authors: Antonio Granata1, Rosario Maccarrone2, Luca Di Lullo3, Walter Morale1, Giovanni Giorgio Battaglia4, Pierpaolo Di Nicolò5, Antonio Bellasi6, Francesco Pesce7, Emad Khater8, Loreto Gesualdo7, Antonio Basile9, Maurizio Gallieni10,11
  2. Rescue Therapy With Pegcetacoplan in a Patient With Proliferative Glomerulonephritis With Monoclonal Immunoglobulin Deposits
    Kidney International Reports. Vol. 11, Issue 3. Published online: January 7, 2026.
    Hormaz Dastoor, Emad Khater, Suhail Al Salam, Stephen G. Holt.
  3. Multicentre Review of Glomerular Diseases in the Emirates of Abu Dhabi: Six Years’ Experience
    Year: 2020 | Volume: 31 | Issue: 5 | Pages: 1069-1077.
    Hefsa Al Shamsi1, Reem El Tahrawi2, Basim Hindawy3, Emad Khater1, Mohamed Hassan1
    1 Department of Nephrology, Sheikh Khalifa Medical City Health Authority, Abu Dhabi, United Arab Emirates.
    2 Department of Internal Medicine, Sheikh Khalifa Medical City Health Authority, Abu Dhabi, United Arab Emirates.
    3 Department of Pathology, Sheikh Khalifa Medical City Health Authority, Abu Dhabi, United Arab Emirates.

Dr. Thangavelu Chandrasekar

Peer-Reviewed Publications

  1. Farooq V, Hegarty J, Chandrasekar T, Lamerton EH, Mitra S, et al. Serious adverse incidents with the usage of low molecular weight heparins in patients with chronic kidney disease. Am J Kidney Dis. 2004;43(3):531–537.
  2. Chandrasekar T, Sharma A, Tennent L, Wong C, Chamberlain P, et al. A whole system approach to improving mortality associated with acute kidney injury. QJM. 2017;110(10):657–666.
  3. Raman KS, Chandrasekar T, Reeve RS, Roberts ME, Kalra PA. Influenza vaccine-induced rhabdomyolysis leading to acute renal transplant dysfunction. Nephrol Dial Transplant. 2006;21(2):530–531.
  4. Mehrotra R, Stanaway IB, Jarvik GP, Lambie M, Morelle J, Perl J, Chandrasekar T, et al. Genome-wide association study suggesting correlations of common genetic variants with peritoneal solute transfer rates in patients receiving peritoneal dialysis. Kidney Int. 2021;100(5):1101–1111.
  5. Ahmed W, Al Obaidli AAK, Joseph P, Smith ER, Khan AA, Anwar S, Chandrasekar T, et al. Outcomes of patients with end-stage kidney disease on dialysis with COVID-19 in Abu Dhabi, UAE: From PCR to antibody. BMC Nephrol. 2021;22:198.
  6. Chandrasekar T, Naqvi N, Waddington A, Cooke RPD, Anijeet H, et al. Intravenous immunoglobulin therapy for refractory Clostridium difficile toxin colitis in chronic kidney disease. NDT Plus. 2008;1(1):20–22.

Conference Abstracts & International Presentations

  1. Chandrasekar T et al. STOP-AKI Project: A streamlined approach to AKI management leading to reduction of in-hospital mortality, length of stay and AKI progression. Nephrology Dialysis Transplantation (2016).
  2. Master J, Hammad S, Chamberlain P, Chandrasekar T, Wong C. Reduction in Acute Kidney Injury Mortality. Nephrology Dialysis Transplantation (2015).
  3. Chukwu C, Macglashan A, Chandrasekar T, Abraham A. Peritoneal Dialysis in the Cloud: The use of a cloud-based remote monitoring device in PD therapy. Nephrology Dialysis Transplantation (2017).
  4. Chandrasekar T et al. Improving the process measures in acute kidney injury – does it correlate with better outcomes? Nephrology Dialysis Transplantation (2017).

UAE & International Nephrology Congress Abstracts

  1. Chandrasekar T, Ponnambath A, Puthoor S, Al Obaidli A, Al Madani A et al. Enhancing Peritoneal Dialysis Utilisation at SEHA Kidney Care: Exploring factors and potential solutions. ISPD Congress (Dubai) 2024.
  2. Chandrasekar T, Ponnambath A, Puthoor S, Al Obaidli A, Al Madani A et al. Peritoneal Dialysis Exit Site Care and Exit Site Infections – Observational data from SEHA Kidney Care PD programme. ISPD Congress (Dubai) 2024.
  3. Chandrasekar T, Ponnambath A, Puthoor S, Al Obaidli A, Al Madani A et al. Peritoneal Dialysis-associated Peritonitis and PD utilisation in Abu Dhabi. ISPD Congress (2024).
  4. Al Shamsi H, Al Shamsi I, Chandrasekar T. Reviving the use of acute peritoneal dialysis in a tertiary centre in Abu Dhabi. ISPD Congress (2022).
  5. Al Shamsi H, Al Shamsi I, Chandrasekar T. Outcomes of Sotrovimab use in peritoneal dialysis patients with COVID-19 infection in SEHA Kidney Care. ISPD Congress (2022).
  6. Ahmed W, Al Obaidli AAK, Joseph P, Smith E, Khan A, Anwar S, Chandrasekar T et al. Outcomes of patients with End-Stage Kidney Disease on dialysis with COVID-19: From PCR to antibody. (2020).
  7. Chandrasekar T, Varghese S, Puthoor SS et al. Peritoneal Dialysis Programme at SEHA Kidney Care, Emirate of Abu Dhabi – Challenges and opportunities. Kidney International Reports (2020).
  8. Ahmed W, Chandrasekar T, Khan A, Anwar S et al. Increasing use of IV iron for patients on haemodialysis results in reduction in erythropoietin dose while maintaining haemoglobin targets. Kidney International Reports (2020).
  9. Al Shamsi H, Syed M, Al Shamsi I et al. Cost analysis of parathyroidectomy for severe uncontrolled secondary hyperparathyroidism in UAE. Kidney International Reports (2020).

Dr. Mohammed Budruddin

Publications

  1. Remitting Seronegative Symmetrical Synovitis with Pitting Edema (RS3PE) in Dialysis patient
    Fatima Al Kindi, Nihal Al Bashir, Ahmad Chaaban, Abraham George, Mohamed Saad, Mohammad Al Hakim, Mohammad Budruddin, Imran Khan, Yousef Boobes.
    Journal of Clinical Rheumatology and Immunology 23(Suppl) 2023. doi: 10.1142/S2661341723740413.
  2. Outcomes of Malignancy in Kidney Transplant Recipients.
    F Al Kindi, M Al Blooshi, A al Awadhi, A Alam, M alHakim, A Chaaban, H El Jacck, M Budruddin, K Mzayen, I Khan, Y Boobes.
    Kidney International Reports, Volume 6, Issue 4, Supplement 2021, page S301, ISSN 2468-0249.
    doi: 10.1016/j.ekir.2021.03.722
  3. Posterior Reversible Encephalopathy Syndrome in dialysis Patients and Kidney Disease.
    F Al Kindi, Al Khoori, M Al Hakim, A Chaaban, H ElJack, M Budruddin, K Mzayen, I Khan, Y Boobes.
    Kidney International Volume 6, Issue 4, Supplement 2021, page S219, ISSN 2468-0249.
    doi: 10.1016/j.ekir.2021.03.533
  4. Risks and Benefits of warfarin Use for cardiac Indications in Dialysis.
    Chaaban A, Gebran N, Abdelmegid K, Soliman K, Aha L, Butt S, M Budruddin, El Jack H, Bernieh B, Boobes Y, Abouchacraq S, Hakim M, Tarifi H, Hussain H, Ahmed A, Khan I.
    Journal of Applied Medical Sciences 2016;5:9-16.
  5. Use of recombinant Human Parathyroid Hormone to treat Hungary Bone disease in Hemodialysis patient.
    Ahmed Chaaban, Fatma Alkendi, Nicole Gebaran, Clarrise Barcebal, Khalid Dahmani, Ali el Houni, Mohammad Budruddin.
    Oman Medical Journal, vol. 35, No. 4, October 2020. e164.
  6. Patients Returning to Dialysis after Failed kidney transplant: How do they Fare? A Gulf Perpective.
    Samra Abouchacra, Ahmed Chaaban, Abdel Karim Saleh, Muna Rukhaimi, Osman Furaih, Naved Ul Haq, Mohamed Osman, Nicole Geberan, Qutaiba Hussain, Fares Chedid, Mohammad Budruddin, Suad Sajwani.
    Open Journal of Internal Medicine, Vol. 4, No. 3, September 10, 2014:82-86.
  7. Before the Jury is out on Cinacalcet’s Cardiovascular effects in Hemodialysis patients: Is Troponin a missing link?
    Samra Abouchacra, Ahmed Chaaban, Mohammad Budruddin, Fares Chedid, Mohamed Hakim, Mohamad Ahmed, Nicole Geberan, Farida Marzouki, MuhyEddin Hassan, Faiz AlAbbacheyi.
    Open Journal of Nephrology, Vol. 4, No. 1, March 24, 2014:47-53.
  8. Experience with post transplant Parathyroidectomy in Gulf region and review of literature.
    Samra Abouchacra, Ahmed Chaaban, Ammar Abdel Baki, Khalid Al mashari, Saif Al Sobhi, Atia Al Zaharani, Qutaiba Hussain, Nicole Gebaran, Mohamed Ahmed, Imran Khan, Bassam Bernieh, Mohammad Budruddin.
    Open Journal of Nephrology, Vol. 3, No. 4, December 17, 2013:211-216.
  9. Alarming presentation of a seemingly common condition in a patient with renal impairment.
    Mohammad Budruddin, Muhammad Yasir Khalil, Issa Salmi, Ramaiah Shilpa.
    Open Journal of Nephrology, Vol. 3, No. 4, December 13, 2013:181-183.
  10. Renal Allograft Thrombosis in the Early Post Transplant Period.
    M Budruddin, Issa Al Salmi, R. Shilpa.
    OJNeph, Volume 3, Number 3, September 2013. doi: 10.4236/ojneph.2013.33027.
  11. Calcium Kinetic in patient with acute renal failure due to Rhabdomyolysis: A case report and review of Literature.
    Abbas Pakkyara, Nabil Mohsin, Mohammad Budruddin, Amitabh J, E Mohammad, Khalil Mohammad.
    Oman Medical Journal 2010, Volume 25, Issue 4, October 2010. doi: 10.5001/omj.2010.93.
  12. Attitude of the omani population toward organ transplantation.
    Mohsin N, Militsala E, Budruddin M, Al-Khawaldi H, Al Dhuhli Y, Al Rahbi, Al-Lawati J.
    Transplant Proc. 2010 Dec;42(10):4305-8.
  13. Emphysematous pyelonephritis. a case report series of 4 patients with review of literature.
    Mohsin N, Budruddin M, Lala S, Al Taie S.
    Ren Fail. 2009;31(7):597-601.
  14. Acute Tubular Necrosis Associated with Non Haemorrhagic Dengue Fever, A Case Report.
    Mohsin N, Mohamed E, Gaber M, Obaidani I, Budruddin M, AlBusaidy S.
    Ren Fail. 2009;31(8):736-9.
  15. Femoral vein tunneled cathetes as a last resort vascular access. Report of five cases and review of literature
    Budruddin M, Mohsin N, Amitabh J, Ehab M, Pramod K, abbas P, Khalil M, Al-Lawati S.
    Ren Fail. 2009;31(4):320-2.
  16. Fatal Acute Purulent pericarditis in a Renal Transplant Patient – A Case Report.
    Mohsin N, Budruddin M, Amitabh J, Ehab M, and Abbas P.
    Exp Clin Transplant. 2009 Mar;7(1):62-5.
  17. Selenium intoxication with selenite broth resulting in acute renal failure and severe gastritis.
    Kamble P, Mohsin N, Jha A, Date A, Upadhaya A, Mohammad E, Khalil M, Pakkyara A, Budruddin M.
    Saudi J Kidney Dis Transpl. 2009 Jan;20(1):106-11.
  18. Acute renal failure in a patient with both letospirosis and dengue fever.
    Ehab Mohammad, Nabil Mohsin, Saif Al-Abri, Idris Al-Abaidani, Amitabh Jha, Pramod Camble, Mohammad Budruddin, Mohammad Khalil, Abbas Pakyarra, Sulaiman Al Busaidy.
    OMJ, April 2008, Vol. 23, No. 2, pp. 101-103.
  19. Retinal injury as an early manifestation of posttransplant thrombotic microangiopathy: recovery with plasma exchanges and conversion to sirolimus–case report and review of the literature.
    Mohsin N, Nooyi C, Jha A, Budruddin M, Kamble P, Khalil M, Pakkyarra A, Mohammed E, Ahmed H, Daar A.
    Transplant Proc. 2007 May;39(4):1272-5.
  20. Complete regression of cutaneous B-cell lymphoma in a renal transplant patient after conversion from cyclosporin to sirolimus.
    Mohsin N, Budruddin M, Kamble P, Khalil M, Pakkyarra A, Jha A, Mohammed E, Ahmed H, Ahmed J, Thomas S, Campistol JM, Daar A.
    Transplant Proc. 2007 May;39(4):1267-71.
  21. Donor gender balance in a living-related kidney transplantation program in Oman.
    Mohsin N, Budruddin M, Khalil M, Pakkyarra A, Jha A, Mohammed E, Kamble P, Ahmed H, Militsala E, Prabhakar NA, Al-Marhuby H, Ahmed J, Daar A.
    Transplant Proc. 2007 May;39(4):803-6.
  22. Complete regression of visceral Kaposi’s sarcoma after conversion to sirolimus.
    Mohsin N, Budruddin M, Pakkyara A, Darweesh A, Nayyer M, Amitabh J, Daar A.
    Exp Clin Transplant. 2005 Dec;3(2):366-9.
  23. High incidence of early post-transplantation diabetes mellitus in an eastern population.
    Mohsin N, Budruddin M, Pakkyara A, Kumar A, Kalankara S, Malvathu S, Amitabh J, Daar A.
    Transplant Proc. 2005 Sep;37(7):3093-4.
  24. Low tacrolimus dose requirements in renal transplant recipients in the omani population: implications for pharmacogenetics?
    Mohsin N, Pakkyara A, Budruddin M, Obaid F, Kumar A, Malvathu S, Kalankara S, Amitabh A, Daar A.
    Transplant Proc. 2005 Sep;37(7):2911-2.

Accepted Abstracts

  1. Its rare but there: Severe Angioedema Following Rituximab Treatment for Severe Lupus Nephritis.
    Kidney International Reports, Volume 10, Issue 2, S773, February 2025.
    Nihal Bashir, Yousef Boobes, Mohamed Al Hakim, Mohamed Saad, Mohammad Budruddin, Ahmad Chaaban, Abraham George, Imran Khan, Osama Al Ouda, Suhail Al Salam, Fatima Al Kindi, Roger Barranco, Qazi Jehanzeb.
  2. IgA Dominant Infection Related Glomerulonephritis.
    Kidney International Reports, Volume 10, Issue 2, Supplement S190-S191, February 2025.
    Fatima Al Kindi, Suhail Al Salam, Mohamed H Hasssan, Ahmad Chaaban, Mohammad al Hakim, Nihal Bashir, George Abraham, Mohamed Saad, Imran Khan, Mohammad Budruddin, Asma A Neyadi, Yoused Boobes.
  3. Prevalence of Hepatitis C and B in Hemodialysis patients in United Arab Emirates over two decades. One center Experience.
    Conference paper for 9th International Congress of the International Society for Hemodialysis, September 2015, Kuala Lumpur, Malaysia.
    Y Boobes, B Bernieh, Mohammad Rafat Hakim, A Ahmed, Q Hussain, A Chaaban, H El Jack, I Khan, M Budruddin.
  4. Dilema regarding the management of ESRD in Patients who develop Vegetative state.
    Conference paper for American Society of Nephrology meeting, April 2015.
    A Chaaban, B Bernieh, S Abouchara, Y Boobes, Mohammad rafat Hakim, N Gebaran, I Khan, Q Hussain, H El Jack, M Budruddin, A Ahmed, Mohd Osman.
  5. Acute kidney injury in UAE, incidence, etiology and outcome. One center experience.
    Conference paper for World Congress of Nephrology, March 2015, Cape Town, South Africa.
    B Bernieh, Y Boobes, Mohd Rafat Hakim, Q Hussain, M Ahmed, M Budruddin, A Ahmed, I Khan, A Chaban, H El Jack.
  6. Continuation or withdrawal of dialysis in patients who developed vegetative state (VS): An ethical, legal and professional dilemma. Accepted for oral presentation in NKF spring meeting, February 2014.
  7. Cinacalcet-Troponin: Is there an undiscovered Link. Accepted for poster presentation in ASN Meeting in November 2013.
  8. Cinacalcet effects on PTH and cardiac troponins: Are they time dependent? Accepted for poster presentation in WCN Congress at Hong Kong in June 2013 (Presented).
  9. The effect of cinacalcet-associated troponin changes on cardiovascular event rates in hemodialysis patients-A possible Link? Accepted for poster presentation in NKF meeting in 2013.
  10. Renal allograft thrombosis in the early post transplant period. Accepted for poster presentation in the New Zealand and Australian Society of Nephrology meeting at Auckland in October 2012.
  11. Atypical presentation of acute pulmonary oedema in a patient with advanced renal failure. Accepted for poster presentation in New Zealand and Australian Society of Nephrology Meeting at Auckland in October 2012.
  12. Retinal Injury as an early manifestation of post transplant thrombotic micro-angiopathy. Accepted for poster presentation in MESOT Congress at Kuwait, in October 2006 (Presented).
  13. High incidence of early post transplant diabetes mellitus in the eastern population. Accepted for oral presentation in MESOT Congress at Ankara, Turkey in November 2004 (Presented).
  14. Low dose Tacrolimus requirement in renal transplant recipients in eastern population. Accepted for oral presentation in MESOT Congress at Ankara, Turkey in November 2004 (Presented).

Dr. Kevin Thankachan Keeppalli

Publications

  1. Elayaperumal I, Keeppallil KTJ, Jose N, Matcha J. Leptospirosis-associated acute kidney injury—still a major burden in tropical countries? Turk J Nephrol. 2025;34(4):281–288.
  2. Jose N, S M, John K, Prasad R, Jayakumar M. CLABSI in hemodialysis—new face to an old foe: a look at current trends and a review of literature. Open Urol Nephrol J. 2022;15(1). doi:10.2174/1874303X-v15-e2208180.
  3. John KT, Karnam AHF, Kandasamy R, Sarangi R, Iqbal N, Nanda SK. Copeptin: Short-term prognostic biomarker in ischemic stroke among Indian patients—a prospective cohort study. J Curr Res Sci Med. 2020;6(2):77–83. doi:10.4103/jcrsm.jcrsm_31_20.

2021

  1. Bressendorff I, Hansen D, Pasch A, Holt SG, Schou M, Brandi L, Smith ER. The effect of increasing dialysate magnesium on calciprotein particles, inflammation and bone markers: post hoc analysis from a randomized controlled clinical trial. Nephrol Dial Transplant 2021; 36: 713-721. 10.1093/ndt/gfz234.
  2. Tiong MK, Krishnasamy R, Smith ER, Hutchison CA, Ryan EG, Pascoe EM, . . . Toussaint ND. Effect of a medium cut-off dialyzer on protein-bound uremic toxins and mineral metabolism markers in patients on hemodialysis. Hemodial Int 2021; 25: 322-332. 10.1111/hdi.12924.
  3. Smith ER, Hewitson TD. HBEGF: an EGF-like growth factor with FGF23-like activity? Kidney Int 2021; 99: 539-542. 10.1016/j.kint.2020.11.011.
  4. AlSahow A, Muenz D, Al-Ghonaim MA, Al Salmi I, Hassan M, Al Aradi AH, . . . Pisoni RL. Kt/V: achievement, predictors and relationship to mortality in hemodialysis patients in the Gulf Cooperation Council countries: results from DOPPS (2012-18). Clin Kidney J 2021; 14: 820-830. 10.1093/ckj/sfz195.
  5. Sypek MP, Kausman JY, Watson N, Wyburn K, Holt SG, Hughes P, Clayton PA. The Introduction of cPRA and Its Impact on Access to Deceased Donor Kidney Transplantation for Highly Sensitized Patients in Australia. Transplantation 2021; 105: 1317-1325. 10.1097/tp.0000000000003410.
  6. Tiong MK, Smith ER, Toussaint ND, Al-Khayyat HF, Holt SG. Reduction of Calciprotein Particles in Adults Receiving Infliximab for Chronic Inflammatory Disease. JBMR Plus 2021; 5: e10497. 10.1002/jbm4.10497.
  7. Reis T, Anwar S, Neves F, Ronco C. Disruptive technologies for hemodialysis: medium and high cutoff membranes. Is the future now? J Bras Nefrol 2021; 43: 410-416. 10.1590/21758239-jbn-2020-0273.
  8. Thwaites SE, Holt SG, Yii MK. Inferiority of arteriovenous grafts, in comparison to autogenous fistulas, is underestimated by standard survival measures alone. ANZ J Surg 2021; 91: 162-167. 10.1111/ans.16472.
  9. Holt SG, Locarnini S, Sasadeusz J. Hepatitis B related dilemmas in the renal unit. Nephrology (Carlton) 2021; 26: 287-293. 10.1111/nep.13815.
  10. Hewitson TD, Smith ER. A Metabolic Reprogramming of Glycolysis and Glutamine Metabolism Is a Requisite for Renal Fibrogenesis—Why and How? Front Physiol 2021; 12: 288.
  11. Moodie J-A, Sanders E, Sobey B, Ryan J, Amy J, Beavis J, Montgomery A, Holt SG. The advantages of nurse-led consent for dialysis in improving shared decision-making and obtaining legal consent. Renal Society of Australasia Journal 2021; 17: 4-9.
  12. Steinberg AG, Beavis J, Sobey B, Holt SG. Individual versus group chronic kidney disease education. Renal Society of Australasia Journal 2021; 17: 17-23.

2022

  1. Toussaint ND, Damasiewicz MJ, Holt SG, Lu ZX, Magliano DJ, Atkins RC, Chadban SJ, Shaw JE, Polkinghorne KR. Relationship Between Urinary Phosphate and All-Cause and Cardiovascular Mortality in a National Population-Based Longitudinal Cohort Study. J Ren Nutr 2022; 32: 510-519. 10.1053/j.jrn.2021.10.009.
  2. Madam AA, Ahmed W, Al Obaidli AAK, Smith ER, Holt SG. Coronavirus Disease 2019 Infection and ABO Blood Groups in a Hemodialysis Cohort in the United Arab Emirates. Saudi J Kidney Dis Transpl 2022; 33: 413-417. 10.4103/1319-2442.385964.
  3. Tiong MK, Cai MMX, Toussaint ND, Tan SJ, Pasch A, Smith ER. Effect of nutritional calcium and phosphate loading on calciprotein particle kinetics in adults with normal and impaired kidney function. Sci Rep 2022; 12: 7358. 10.1038/s41598-022-11065-3.
  4. Xu C, Smith ER, Tiong MK, Ruderman I, Toussaint ND. Interventions To Attenuate Vascular Calcification Progression in Chronic Kidney Disease: A Systematic Review of Clinical Trials. J Am Soc Nephrol 2022; 33: 1011-1032. 10.1681/ASN.2021101327.
  5. Holt SG, Mahmoud S, Ahmed W, Acuna JM, Al Madani AK, Eltantawy I, . . . Al Obaidli AA. An analysis of antibody responses and clinical sequalae of the Sinopharm HB02 COVID19 vaccine in dialysis patients in the United Arab Emirates. Nephrology (Carlton) 2022; 27: 260-268. 10.1111/nep.13980.
  6. Al Kaabi N, Oulhaj A, Ganesan S, Al Hosani FI, Najim O, Ibrahim H, . . . Zaher W. Effectiveness of BBIBP-CorV vaccine against severe outcomes of COVID-19 in Abu Dhabi, United Arab Emirates. Nat Commun 2022; 13: 3215. 10.1038/s41467-022-30835-1.
  7. Ethier I, Boudville N, McDonald S, Brown F, Kerr PG, Walker R, . . . Johnson DW. Representativeness of the PDOPPS cohort compared to the Australian PD population. Perit Dial Int 2022; 42: 403-414. 10.1177/08968608211056242.
  8. Bruell S, Nicholls KM, Hewitson TD, Talbot AS, Holt SG, Smith ER, Ruderman I. Reduced hip bone mineral density is associated with high levels of calciprotein particles in patients with Fabry disease. Osteoporos Int 2022; 33: 1783-1794. 10.1007/s00198-022-06420-z.
  9. Al Madani AK, Al Obaidli AK, Ahmed W, AlKaabi NA, Holt SG. The Omicron COVID-19 threat to dialysis patients is dramatically lower than previous variants. Nephrology (Carlton) 2022; 27: 725-726. 10.1111/nep.14065.
  10. Tiong MK, Holt SG, Ford ML, Smith ER. Serum Calciprotein Monomers and Chronic Kidney Disease Progression. Am J Nephrol 2022; 53: 806-815. 10.1159/000526609.
  11. Jha CM, Dastoor HD, Gopalakrishnan N, Holt SG. Obstacles to Early Diagnosis and Treatment of Pruritus in Patients with Chronic Kidney Disease: Current Perspectives. Int J Nephrol Renovasc Dis 2022; 15: 335-352. 10.2147/ijnrd.S294147.
  12. Champion de Crespigny PJ, Cai MX, Holt SG. Providing a PD Service. In: Harber M (ed). Primer on Nephrology. Springer International Publishing: Cham, 2022, pp 1385-1408.

2023

  1. Holt SG, Nundlall A, Alameri M, Alhosani KJ, Arayaparath AV, James MK, . . . Al Madani AK. Quantifying the advantages and acceptability of linking dialysis machines to an electronic medical record. Int J Med Inform 2023; 178: 105215. 10.1016/j.ijmedinf.2023.105215.
  2. Komaba H, Zhao J, Karaboyas A, Yamamoto S, Dasgupta I, Hassan M, . . . Fukagawa M. Active Vitamin D Use and Fractures in Hemodialysis Patients: Results from the International DOPPS. J Bone Miner Res 2023; 38: 1577-1585. 10.1002/jbmr.4913.
  3. Alvares M, Anwar S, Hashmi SK, Zaman MB, Al Mahri A, Alvares C, . . . ElGhazali G. Development of a calculated panel reactive antibody calculator for the United Arab Emirates: a proof of concept study. Sci Rep 2023; 13: 8468. 10.1038/s41598-023-34860-y.
  4. Thiem U, Hewitson TD, Toussaint ND, Holt SG, Haller MC, Pasch A, Cejka D, Smith ER. Effect of the phosphate binder sucroferric oxyhydroxide in dialysis patients on endogenous calciprotein particles, inflammation, and vascular cells. Nephrol Dial Transplant 2023; 38: 1282-1296. 10.1093/ndt/gfac271.
  5. AlSahow A, AbdulShafy M, Al-Ghamdi S, AlJoburi H, AlMogbel O, Al-Rowaie F, . . . Zannad F. Prevalence and management of hyperkalemia in chronic kidney disease and heart failure patients in the Gulf Cooperation Council (GCC). J Clin Hypertens (Greenwich) 2023; 25: 251-258. 10.1111/jch.14633.
  6. Al-Ani FM, Khandoker AH, Corridon PR, Holt SG. A novel model for predicting hospitalization risk among hemodialysis patients based on blood test variables. Annu Int Conf IEEE Eng Med Biol Soc 2023; 2023: 1-4. 10.1109/embc40787.2023.10340227.
  7. Zeper LW, Smith ER, Ter Braake AD, Tinnemans PT, de Baaij JHF, Hoenderop JGJ. Calciprotein Particle Synthesis Strategy Determines In Vitro Calcification Potential. Calcif Tissue Int 2023; 112: 103-117. 10.1007/s00223-022-01036-1.
  8. Tiong MK, Smith ER, Pascoe EM, Elder GJ, Lioufas NM, Pedagogos E, . . . Toussaint ND. Effect of lanthanum carbonate on serum calciprotein particles in patients with stage 3-4 CKD-results from a placebo-controlled randomized trial. Nephrol Dial Transpl 2023; 38: 344-351. 10.1093/ndt/gfac043.
  9. Murali S, Smith ER, Tiong MK, Tan SJ, Toussaint ND. Interventions to Attenuate Cardiovascular Calcification Progression: A Systematic Review of Randomized Clinical Trials. J Am Heart Assoc 2023; 12: e031676. 10.1161/JAHA.123.031676.
  10. Smith ER, Champion de Crespigny PJ, Vally F, Hewitson TD, Toussaint ND, Cade TJ, Holt SG. Cord blood effectively resists mineralization through mechanisms that stabilize calciprotein particles. Kidney Int 2023; 103: 782-786. 10.1016/j.kint.2022.11.019.
  11. Hewitson TD, Toussaint ND, Smith ER (eds). Kidney Research. Humana: NY, 2023. 353pp.
  12. Hewitson TD, Smith ER. Propagation, Culture, and Characterization of Renal Fibroblasts. Methods Mol Biol 2023; 2664: 13-29. 10.1007/978-1-0716-3179-9_2.
  13. Hewitson TD, Smith ER. Isolation of Rat Glomeruli and Propagation of Mesangial Cells to Study the Kidney in Health and Disease. Methods Mol Biol 2023; 2664: 31-39. 10.1007/978-1-0716-3179-9_3.
  14. Al-Ghamdi S, Abu-Alfa A, Alotaibi T, AlSaaidi A, AlSuwaida A, Arici M, . . . Sqalli T. Chronic Kidney Disease Management in the Middle East and Africa: Concerns, Challenges, and Novel Approaches. Int J Nephrol Renovasc Dis 2023; 16: 103-112. 10.2147/ijnrd.S363133.
  15. Schuck KE, Holt SG, Hosking J, McNeill L, Bennett P. The Australian and New Zealand dialysis workforce study 2021. Renal Society of Australasia Journal 2023; 19: 100-107.
  16. Al Dhaheri AF, Al Hammadi AA, Boni CR, Randhawa AA, Nsutebu FE, Mooty M, Al Seiari YM, Holt GS, Al Obaidli AA. Solid Organ Transplantation from SARS-CoV-2–infected Donor to Uninfected Recipients: First in the United Arab Emirates and the Neighboring Region. New Emirates Medical Journal 2023; 4: 1-4. 10.2174/04666230317104250.

2024

  1. Almadani AK, Ahmed W, Al Obaidli AAK, Holt SG. Gender, age and nationality differences in chronic kidney disease prevalence in the emirate of Abu Dhabi, UAE. Nephrology (Carlton) 2024; 29: 288-296. 10.1111/nep.14285.
  2. AlKindi F, Saedi MA, Boobes Y. New Onset Plaque Psoriasis in a Hemodialysis Patient: A Case Report and Review of Literature. Indian J Nephrol 2024; 34: 195-197. 10.4103/ijn.ijn_57_22.
  3. Boobes Y, Afandi B, AlKindi F, Tarakji A, Al Ghamdi SM, Alrukhaimi M, . . . Al-Hakim MR. Consensus recommendations on fasting during Ramadan for patients with kidney disease: review of available evidence and a call for action (RaK Initiative). BMC Nephrol 2024; 25: 84. 10.1186/s12882-024-03516-y.
  4. Hamid AK, Pastor Arroyo EM, Calvet C, Hewitson TD, Muscalu ML, Schnitzbauer U, Smith ER, Wagner CA, Egli-Spichtig D. Phosphate Restriction Prevents Metabolic Acidosis and Curbs Rise in FGF23 and Mortality in Murine Folic Acid-Induced AKI. J Am Soc Nephrol 2024; 35: 261-280. 10.1681/ASN.0000000000000291.
  5. Chertow GM, Correa-Rotter R, Eckardt KU, Kanda E, Karasik A, Li G, . . . Retat L. Projecting the clinical burden of chronic kidney disease at the patient level (Inside CKD): a microsimulation modelling study. EClinicalMedicine 2024; 72: 102614. 10.1016/j.eclinm.2024.102614.
  6. Bulanov N, Alshamsi I, Cambier A, Chávez-Iñiguez JS, Gallardo M, Malik C, . . . Karam S. Toolkit on Creating a Young Nephrologists Committee: An ISN Young Nephrologists Committee Project to Empower Young Nephrologists Worldwide. Kidney Int Rep 2024; 9: 1553-1556. 10.1016/j.ekir.2024.04.011.
  7. Cejka D, Thiem U, Blinzler E, Machacek J, Voelkl J, Smith ER, Pasch A, Haller MC. Citrate-Buffered, Magnesium-Enriched Dialysate on Calcification Propensity in Hemodialysis Patients – The CitMag Study. Kidney Int Rep 2024; 9: 1765-1773. 10.1016/j.ekir.2024.03.023.
  8. AlKindi F, AlHaj O, Alhanaee A, Almazrouei R, Boobes Y. Severe Hyponatremia Associated With Terlipressin Use in Esophageal Variceal Bleeding. Cureus 2024; 16: e64576. 10.7759/cureus.64576.
  9. AlKindi F, Boobes Y, Shalwani F, Ansari J, Almazrouei R. Sodium-Glucose Cotransporter 2 Inhibitor (SGLT2i) Associated Diabetic Ketoacidosis in Oncology Patients: A Case Series and Literature Review. Cureus 2024; 16: e53816. 10.7759/cureus.53816.
  10. Feenstra L, Reijrink M, Pasch A, Smith ER, Visser LM, Bulthuis M, . . . Hillebrands JL. Calciprotein particle counts associate with vascular remodelling in chronic kidney disease. Cardiovasc Res 2024. 10.1093/cvr/cvae164.
  11. Karam S, Amouzegar A, Alshamsi IR, Al Ghamdi SMG, Anwar S, Ghnaimat M, . . . Savaj S. Capacity for the management of kidney failure in the International Society of Nephrology Middle East region: report from the 2023 ISN Global Kidney Health Atlas (ISN-GKHA). Kidney Int Suppl (2011) 2024; 13: 57-70. 10.1016/j.kisu.2024.01.009.
  12. Chacar S, Abdi A, Almansoori K, Alshamsi J, Al Hageh C, Zalloua P, Khraibi AA, Holt SG, Nader M. Role of CaMKII in diabetes induced vascular injury and its interaction with anti-diabetes therapy. Rev Endocr Metab Disord 2024; 25: 369-382. 10.1007/s11154-023-09855-9.
  13. Thiem U, Lenz J, Haller MC, Pasch A, Smith ER, Cejka D. The effect of parathyroid hormone lowering by etelcalcetide therapy on calcification propensity and calciprotein particles in hemodialysis patients. Clinical Kidney Journal 2024. 10.1093/ckj/sfae097.
  14. Elkeraie AF, Al-Ghamdi S, Abu-Alfa AK, Alotaibi T, AlSaedi AJ, AlSuwaida A, . . . Sqalli T. Impact of Sodium-Glucose Cotransporter-2 Inhibitors in the Management of Chronic Kidney Disease: A Middle East and Africa Perspective. Int J Nephrol Renovasc Dis 2024; 17: 1-16. 10.2147/ijnrd.S430532.
  15. Holt SG, Korneef E, Al Obaidli A, Hubbert L, Nicholson L. Decarbonisation of Kidney Care in the United Arab Emirates: A Roadmap to an environmentally Sustainable Care. Int J Nephrol Renovasc Dis 2024.

Join Our Newsletter

Stay in the loop with everything you need to know.

Opening Hours

SEHA Kidney Care - Central
Monday - Saturday 6:00 AM–12 AM
Overnight dialysis: Monday, Wednesday, Friday
SEHA Kidney Care - Abu Dhabi
06:00-00:00 daily (closed Sunday)
SEHA Kidney Care - Al Ain
Monday - Saturday 6:00 AM–12 AM